|
Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials
|
3
|
Resverlogix Corp.
|
Jul 28, 2021 07:47AM
|
|
Denali Interim Phase I/II Data for Hunter Syndrome (MPSII) Clinical Program
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 26, 2021 08:03AM
|
|
Epigenetic Therapeutic Targets Summit, 7/15/2021: Clinical Development of ZEN-3694 in Solid Tumors
|
8
|
Zenith Epigenetics
|
Jul 22, 2021 09:58AM
|
|
Re: Let’s see what happens now!
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2021 10:00AM
|
|
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in mCRPC
|
7
|
Zenith Epigenetics
|
Jun 24, 2021 04:11PM
|
|
Re: Reposting with Link Included
|
9
|
Resverlogix Corp.
|
Jun 23, 2021 09:43AM
|
|
Re: AGM
|
1
|
Zenith Epigenetics
|
Jun 21, 2021 08:25AM
|
|
Re: BET inhibition and epilepsy
|
4
|
Resverlogix Corp.
|
Jun 11, 2021 05:52PM
|
|
Re: Long awaited announcement just in…
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 08, 2021 10:17AM
|
|
Re: BET inhibition and epilepsy
|
6
|
Resverlogix Corp.
|
Jun 08, 2021 10:13AM
|
|
Re: Hope never dies....
|
7
|
Resverlogix Corp.
|
Jun 04, 2021 08:19PM
|
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
6
|
Zenith Epigenetics
|
Jun 03, 2021 12:33PM
|
|
German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
8
|
Zenith Epigenetics
|
Jun 03, 2021 10:45AM
|
|
Resverlogix & EVERSANA Announce Partnership to Support the Pending Launch of the Initial Commercialization of Apabetalone for COVID-19 in US & Canada
|
1
|
Resverlogix Corp.
|
Jun 03, 2021 10:38AM
|
|
Re: Wow! Quite the read!
|
8
|
Resverlogix Corp.
|
May 30, 2021 07:48PM
|
|
Re: Where is BDAZ?
|
8
|
Resverlogix Corp.
|
May 15, 2021 12:41PM
|
|
Re: A few upcoming conference appearances
|
5
|
Resverlogix Corp.
|
Apr 28, 2021 11:56AM
|
|
April 29, 2021: Triple Negative Breast Cancer Drug Development Digital Summit 2021
|
8
|
Zenith Epigenetics
|
Apr 28, 2021 11:43AM
|
|
Re: Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
8
|
Resverlogix Corp.
|
Apr 27, 2021 09:24PM
|
|
Resverlogix’s Apabetalone Demonstrates a Medical First in Patients with Chronic Kidney Disease
|
11
|
Resverlogix Corp.
|
Apr 27, 2021 01:46PM
|
